Pfizer: Litfulo safety profile in NSV consistent with alopecia areata
Pfizer Inc. (PFE) stated that the safety profile of its drug Litfulo in Non-Scalp Vitiligo (NSV) is consistent with its use in Alopecia Areata.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.